Drug recall · September 21, 2022
PROPOFOL Injectable Emulsion recall
Why: Presence of particulate matter
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
PROPOFOL Injectable Emulsion, 1 g/100 mL (10 mg/mL), packaged in 100 mL glass fliptop vial (NDC 0409-4699-54) further packaged in a tray of 10 vials (NDC Carton: 0409-4699-24), Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA
- Lots / codes
Lot#: EA7470, Exp 6/1/2023
- Quantity
- 5,390 vials
- Company
- Pfizer Inc., New York, NY
- Distribution
- USA Nationwide
- Initiated
- August 22, 2022 · Voluntary: Firm initiated
- Classified
- September 19, 2022
- Reported
- September 21, 2022
- Ended
- June 30, 2025
- How notified
- Press Release
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Propofol
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.